Milestone Scientific Inc. MLSS
AMEX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 31.41% | 5.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 31.41% | 5.05% | |||
| Cost of Revenue | 55.67% | 7.50% | |||
| Gross Profit | 22.14% | 4.15% | |||
| SG&A Expenses | 24.14% | -6.95% | |||
| Depreciation & Amortization | 0.51% | 1.56% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 30.52% | -4.70% | |||
| Operating Income | -28.20% | 23.30% | |||
| Income Before Tax | -26.12% | 22.99% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -26.12% | 22.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -26.12% | 22.99% | |||
| EBIT | -28.20% | 23.30% | |||
| EBITDA | -28.86% | 23.75% | |||
| EPS Basic | -15.15% | 25.56% | |||
| Normalized Basic EPS | -14.52% | 25.30% | |||
| EPS Diluted | -15.15% | 25.56% | |||
| Normalized Diluted EPS | -14.52% | 25.30% | |||
| Average Basic Shares Outstanding | 9.51% | 3.42% | |||
| Average Diluted Shares Outstanding | 9.51% | 3.42% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||